ISCT, International Society for Cell & Gene Therapy

The ISCT nominations committee is seeking candidates for global and regional leadership positions. If you are an aspiring leader or would like to encourage a peer to apply, please complete the nomination form and submit by January 31, 2025. Learn More: https://buff.ly/4dwlg9s

Are you seeking to unlock funding opportunities for your projects but unsure of where to start? Whether you’re new to grant writing or looking to refine your skills, in this interactive session, we will cover the essentials of navigating the world of grants and funding opportunities from USA and EU perspectives. You will learn the ins and outs of the grant application process, from understanding different funding sources to crafting compelling proposals that resonate with funders. In addition, you will receive guidance on developing a funding plan, along with career strategies that can significantly improve your chances of securing competitive research funding. Register for the ISCT Early-Stage Professionals’ informative webinar designed to equip you with essential skills in grant writing: https://buff.ly/4g4WPlx

CAR Ts for autoimmune diseases. Memory T cells to enhance hematopoietic stem cell transplants. In vivo cell engineering. Clinical progress approaching the market. Discover these topics in the newly announced ISCT 2025 From First-in-Human to Clinical Acceleration program which explores topics arising in moving from Phase I of clinical trials through to marketing authorization, including results of promising Phase II/III clinical trials, discussions of regulatory requirements and barriers to approval, COGs, business models and operational structures to scale up, partnering and investment. Session topics and speakers are online now: https://buff.ly/3DjduTU #ISCT2025

Why submit an abstract to ISCT? Gain visibility, receive feedback, and connect with Key Opinion Leaders and future collaborations from across the globe. Michael Gustafson, Ph.D. (Mayo Clinic) shares a recommendation for abstract presenters. Submit your abstract by January 17 to participate in vital discussions that will advance your CGT research and expand your network: https://lnkd.in/gXPpkExW

Calling all early-stage professionals! Don't miss this opportunity to gain practical experience on an ISCT expert committee and collaborate on real-world projects alongside Key Opinion Leaders from across the globe. Not an ISCT member? Join today to gain access to a host of benefits. Learn more and apply now: https://buff.ly/3ZgCNyh

Why submit an abstract to ISCT? Gain visibility, receive feedback, and connect with Key Opinion Leaders and future collaborations from across the globe. Shin Kawamata (Cyto-Facto Inc.) shares a recommendation for abstract presenters. Submit your abstract by January 17 to participate in vital discussions that will advance your CGT research and expand your network: https://lnkd.in/gXPpkExW

Dendritic cells, Adoptive T cells, TILs, MS-EVs, and Gene Therapies—promising technologies in early stages of clinical development. Explore these topics in the newly announced ISCT 2025 Translation to Clinic program which addresses topics arising in moving from pre-clinical research to First-in-Human studies, including results from promising Phase I clinical trials, process development, clinical trial development with an eye to eventual market-authorization and product launch, early-stage CMC, regulatory requirements, and sustainable business models. Session topics and speakers are online now: https://buff.ly/3DjduTU #ISCT2025

The call for nominations for ISCT Major Awards is now open! ISCT Major Awards recognizes and honours achievements and extraordinary contributions to the field of cell and gene therapy globally. Follow the link below to submit your nominations by February 3, 2025. https://buff.ly/4eWUHLh

Why submit an abstract to ISCT? Gain visibility, receive feedback, and connect with Key Opinion Leaders and future collaborations from across the globe. Hongjun Wang (Medical University of South Carolina) shares a recommendation for abstract presenters. Submit your abstract by January 17 to participate in vital discussions that will advance your CGT research and expand your network: https://lnkd.in/gXPpkExW

The ISCT 2025 Abstract deadline has been extended to January 17, 2025! Join us in New Orleans and showcase your research to over 3,000 international Cell and Gene Therapy professionals. Submit now: https://buff.ly/3Y6laRz